Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Zipf

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
International Journal of Dermatology|July 1, 1992
Vesicular graft-versus-host diseaseC S Schauder, S R Hymes, R P Rapini, et al.
Annals of Hematology|December 1, 1993
Growth factors controlling interleukin-4 action on hematopoietic progenitorsA Ferrajoli, T F Zipf, M Talpaz, et al.
Blood|February 1, 1985
The E rosette-associated antigen of T cells can be identified on blasts from patients with acute myeloblastic leukemiaJ Mirro, G R Antoun, T F Zipf, et al.
Molecular Immunology|September 1, 1988
Characterization of gp39, a B-lymphocyte associated differentiation antigen which is also present on granulocytes and macrophagesG J Lauzon, G R Antoun, B M Longenecker, et al.
Leukemia|February 1, 1995
Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involvedM V Ouspenskaia, D A Johnston, W M Roberts, et al.
Cytokines and Molecular Therapy|March 1, 1995
Monitoring residual disease in acute lymphoblastic leukemia: therapeutic implicationsW M Roberts, T F Zipf, G R Kitchingman, et al.
Lancet (London, England)|April 2, 1994
Minimal residual leukaemiaZ Estrov, M V Ouspenskaia, T F Zipf, et al.
Cancer Research|November 15, 1990
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiationL A Zwelling, M Hinds, D Chan, et al.
Blood|November 1, 1992
Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expressionY Tomiyama, T J Kunicki, T F Zipf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1990
The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RIIE J Gosselin, M F Brown, C L Anderson, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Dermatology|July 1, 1992
Vesicular graft-versus-host diseaseC S Schauder, S R Hymes, R P Rapini, et al.
Annals of Hematology|December 1, 1993
Growth factors controlling interleukin-4 action on hematopoietic progenitorsA Ferrajoli, T F Zipf, M Talpaz, et al.
Blood|February 1, 1985
The E rosette-associated antigen of T cells can be identified on blasts from patients with acute myeloblastic leukemiaJ Mirro, G R Antoun, T F Zipf, et al.
Molecular Immunology|September 1, 1988
Characterization of gp39, a B-lymphocyte associated differentiation antigen which is also present on granulocytes and macrophagesG J Lauzon, G R Antoun, B M Longenecker, et al.
Leukemia|February 1, 1995
Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involvedM V Ouspenskaia, D A Johnston, W M Roberts, et al.
Cytokines and Molecular Therapy|March 1, 1995
Monitoring residual disease in acute lymphoblastic leukemia: therapeutic implicationsW M Roberts, T F Zipf, G R Kitchingman, et al.
Lancet (London, England)|April 2, 1994
Minimal residual leukaemiaZ Estrov, M V Ouspenskaia, T F Zipf, et al.
Cancer Research|November 15, 1990
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiationL A Zwelling, M Hinds, D Chan, et al.
Blood|November 1, 1992
Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expressionY Tomiyama, T J Kunicki, T F Zipf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1990
The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RIIE J Gosselin, M F Brown, C L Anderson, et al.
Pageof 4